Impact of 10- and 13-Valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012

Eurosurveillance

Volumn 20, Issue 10, 2015, Pages

  Weiss, S ^a   Falkenhorst, G ^b   van Der Linden, M ^c   Imohl M ^c   von Kries, R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE; 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE; VACCINE;

ADOLESCENT; AGE; ARTICLE; CHILD; DISEASE SURVEILLANCE; HUMAN; INCIDENCE; MENINGITIS; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; FEMALE; GERMANY; HEALTH SURVEY; IMMUNOLOGY; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; NEWBORN; PNEUMOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; TREATMENT OUTCOME; VACCINATION; VACCINES, CONJUGATE;

EID: 84925437355     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2015.20.10.21057     Document Type: Article

References (24)

1. Robert Koch Institute (RKI). Empfehlungen der Standigen Impfkommission (STIKO) am Robert Koch-Institut: Begrundungen zur allgemeinen Empfehlung der Impfungen gegen Pneumokokken und Meningokokken im Sauglings- und Kindesalter. [Recommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute: Scientific justification for the universal recommendation to vaccinate against pneumoccal and meningococcal disease during infancy and childhood]. Epidemiologisches Bulletin. 2006;31:255-60. Berlin: RKI; 2006. German. Available from: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2006/Ausgabenlinks/31_06.pdf?__blob=publicationFile
2. van der Linden M, Weis S, Falkenhorst G, Siedler A, Imohl M, von Kries R. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children. Vaccine. 2012;30(40):5880-5. http://dx.doi.org/10.1016/j.vaccine.2012.06.068 PMID:22771186
3. Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10(9):e1001517. http://dx.doi.org/10.1371/journal.pmed.1001517 PMID:24086113
4. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine. 2011;29(49):9127-31. http://dx.doi.org/10.1016/j.vaccine.2011.09.112 PMID:21983361
5. Gobel U, Heinrich B, Krauth KA, Steingruber HJ, von Kries R. [Process and outcome quality of the German Paediatric Surveillance Unit (ESPED)]. Klin Padiatr. 2010;222(2):92-7. German. PMID:20146163
6. von Kries R, Siedler A, Schmitt HJ, Reinert RR. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis. 2000;31(2):482-7 .http://dx.doi.org/10.1086/313984 PMID:10987709
7. Ruckinger S, van der Linden M, Reinert RR, von Kries R, Burckhardt F, Siedler A. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine. 2009;27(31):4136-41. http://dx.doi.org/10.1016/j.vaccine.2009.04.057 PMID:19406190
8. Ruckinger S, von Kries R, Reinert RR, van der Linden M, Siedler A. Childhood invasive pneumococcal disease in Germany between 1997 and 2003: variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination. Vaccine. 2008;26(32):3984-6. http://dx.doi.org/10.1016/j.vaccine.2008.04.031 PMID:18495301
9. LaPorte RE, McCarty DJ, Tull ES, Tajima N. Counting birds, bees, and NCDs. Lancet. 1992;339(8791):494-5.http://dx.doi.org/10.1016/0140-6736(92)91103-F PMID:1346847
10. Chapman DG. Some properties of the hypergeometric distribution with applications to zoological sample censuses. Berkeley, CA: University of California Press; 1951.
11. Ruckinger S, van der Linden M, Reinert RR, von Kries R. Efficacy of 7-valent pneumococcal conjugate vaccination in Germany: An analysis using the indirect cohort method. Vaccine. 2010;28(31):5012-6. PMID:20546832
12. Statistisches Bundesamt. [Federal Statistical Office of Germany]. Tabelle B 15. A1 Bevolkerung nach Alters- und Geburtsjahren 2000-2012. [Table B15, A1 Population according to age and birth year 2001-2012]. Wiesbaden: Federal Statistical Office of Germany;2013. Obtained by email from the Federal Statistical Office in Germany (fortschreibung@ destatis.de). German.
13. Armitage P, Berry G. Statistical methods in medical research. 3rd ed. London: Blackwell; 1994.
14. Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean Med Sci. 2013;28(1):4-15. http://dx.doi.org/10.3346/jkms.2013.28.1.4 PMID:23341706
15. Molander V, Elisson C, Balaji V, Backhaus E, John J, Vargheese R, et al. Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes. BMC Infect Dis. 2013;13(1):532. http://dx.doi.org/10.1186/1471-2334-13-532 PMID:24206667
16. Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, et al. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013;32(3):203-7. http://dx.doi.org/10.1097/INF.0b013e318275614b PMID:23558320
17. Statens Serum Institut (SSI). Invasive pneumococcal disease and PCV coverage 2012. EPI-NEWS, No 19, 2013. Copenhagen: SSI; 8 May 2013. Available from: http://www.ssi.dk/English/News/EPI-NEWS/2013/No%2019%20-%202013.aspx
18. Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Andersen PH, Howitz M, et al. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine. 2010;28(14):2642-7. http://dx.doi.org/10.1016/j.vaccine.2010.01.017 PMID:20096392
19. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11(10):760- 8. http://dx.doi.org/10.1016/S1473-3099(11)70090-1 PMID:21621466
20. Jefferson T, Ferroni E, Curtale F, Giorgi Rossi P, Borgia P. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis. 2006;6(7):405-10. http://dx.doi.org/10.1016/S1473-3099(06)70520-5 PMID:16790381
21. Ruggeberg JU, Ketteler K, MacKenzie CR, Von Kries R, Reinert RR, Schroten H. Blood culture sampling rates at a German pediatric university hospita l and incidence of invasive pneumococcal disease. Infection. 2004;32(2):78-81. http://dx.doi.org/10.1007/s15010-004-3104-2 PMID:15057571
22. von Kries R, Weiss S, Falkenhorst G, Wirth S, Kaiser P, Huppertz HI, et al. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany. PLoS One. 2011;6(9):e23955. http://dx.doi.org/10.1371/journal.pone.0023955 PMID:21915270
23. Robert Koch Institute (RKI). Bericht zur Epidemiologie der Influenza in Deutschland, Saison 2009/10. [Report on the epidemiology of influenza in Germany, season 2009/10]. Berlin: RKI; 2010. German. Available from: http://influenza.rki.de/Saisonberichte/2009.pdf
24. O'Brien KL. PCV13 impact evaluations: the obvious and the unpredicted. Pediatr Infect Dis J. 2013;32(3):264-5. http://dx.doi.org/10.1097/INF.0b013e3182787f89 PMID:23558322